The Seeker for this Innocentive Prize Challenge is seeking proposals for alternative synthetic methods for the preparation of a clinical candidate small molecule. A successful solution will present a short, cost-efficient, and scalable route for the preparation of the compound, suitable for multi-tonne manufacture and feasible for implementation in standard pharmaceutical manufacturing facilities.
Awards:- Your IP Rights are protected in this Prize Challenge; the Seeker must pay you an award to obtain them. The best solution has the opportunity to win the award of $50,000 for meeting all must have solution requirements. This Challenge requires a written proposal to be submitted and Awards will be contingent upon the theoretical evaluation and experimental validation of your proposal by the Seeker against the Solution Requirements. To receive an Award, Solvers are required to assign exclusive ownership to the Intellectual Property (IP) in their proposed solution. Solvers will retain all rights to any proposal not Awarded. At the end of the initial evaluation stage of about one month, any proposal selected for experimental validation (finalists) could be subject to up to 6 months of further evaluation.
Deadline:- 30-06-2026
